Paperpal Prime Logo

Clinical Colorectal Cancer : Impact Factor & More

eISSN: 1938-0674pISSN: 1533-0028

Aims and Scope of Clinical Colorectal Cancer

Clinical Colorectal Cancer is a peer-reviewed medical journal published by CIG Media Group (Cancer Information Group) from 2001 to 2010 and by Elsevier since 2011. It publishes original articles describing various aspects of clinical and translational research of gastrointestinal cancers. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of colorectal, pancreatic, liver, and other gastrointestinal cancers. The main emphasis is on recent scientific developments in all areas related to gastrointestinal cancers. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches. Less

Key Metrics

CiteScore
7.4
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.37
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Colorectal Cancer

Clinical Colorectal Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher CIG MEDIA GROUP, LP
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Colorectal Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Colorectal Cancer

Early-Onset Colorectal Cancer: Epidemiology, Etiologic Pathways, and Emerging Prevention Strategies.
  • 1 Oct 2026
  • Clinical colorectal cancer
Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab as Third-Line Treatment in Circulating Tumor DNA-Selected Metastatic Colorectal Cancer (ROMANCE Trial).
  • 1 Oct 2026
  • Clinical colorectal cancer
Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon.
  • 1 Sep 2026
  • Clinical colorectal cancer
Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study.
  • 1 Sep 2026
  • Clinical colorectal cancer
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors.
  • 1 Sep 2026
  • Clinical colorectal cancer
Real-world treatment and outcomes for patients with deficient mismatch repair metastatic colorectal cancer following pembrolizumab availability in Australia
  • 1 Sep 2026
  • Clinical Colorectal Cancer
Early-Onset Colorectal Cancer: Epidemiology, Etiologic Pathways, and Emerging Prevention Strategies.
  • 1 Oct 2026
  • Clinical colorectal cancer
Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab as Third-Line Treatment in Circulating Tumor DNA-Selected Metastatic Colorectal Cancer (ROMANCE Trial).
  • 1 Oct 2026
  • Clinical colorectal cancer
Discordant Dynamics Between Absolute ctDNA and Tumor Fraction During Treatment Monitoring in Metastatic Colorectal Cancer: Evidence of a Dilution Phenomenon.
  • 1 Sep 2026
  • Clinical colorectal cancer
Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study.
  • 1 Sep 2026
  • Clinical colorectal cancer
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors.
  • 1 Sep 2026
  • Clinical colorectal cancer
Real-world treatment and outcomes for patients with deficient mismatch repair metastatic colorectal cancer following pembrolizumab availability in Australia
  • 1 Sep 2026
  • Clinical Colorectal Cancer

FAQs on Clinical Colorectal Cancer